ClinicalTrials.Veeva
Menu

Find clinical trials for Lung Cancer in San Diego, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Lung Cancer trials near San Diego, CA, USA:

Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: DS-1062a

Phase 2

Daiichi Sankyo
Daiichi Sankyo

La Jolla, California, United States and 83 other locations

a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...

Enrolling
Metastatic Non Small Cell Lung Cancer
Biological: LN-145

Phase 2

Iovance Biotherapeutics

La Jolla, California, United States and 43 other locations

with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....

Active, not recruiting
Non-small Cell Lung Cancer
Drug: DS-1062a
Drug: Docetaxel

Phase 3

Daiichi Sankyo
Daiichi Sankyo

La Jolla, California, United States and 205 other locations

This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...

Active, not recruiting
Non-Small Cell Lung Cancer Metastatic
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Drug: Patritumab Deruxtecan (Fixed dose)
Drug: Patritumab Deruxtecan (Up-Titration)

Phase 2

Daiichi Sankyo
Daiichi Sankyo

La Jolla, California, United States and 123 other locations

The purpose of the study is to determine whether plinabulin (also known as BPI-2358) has an effect on cancer and body in combination with ni ...

Active, not recruiting
Non-small Cell Lung Cancer Metastatic
Drug: Nivolumab + Plinabulin

Phase 1

Lyudmila Bazhenova, M.D.

La Jolla, California, United States

the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...

Active, not recruiting
Lung Cancer
Drug: Itacitinib
Drug: Osimertinib

Phase 1, Phase 2

Incyte
Incyte

La Jolla, California, United States and 30 other locations

This study is designed to evaluate safety and antitumor activity of HER3-DXd in two parts: Dose Escalation and Dose Expansion.In Dose Escalation, HER...

Enrolling
Non-Small Cell Lung Cancer (NSCLC)
Drug: HER3-DXd (CTM-1 Lyo-DP)
Drug: HER3-DXd (CTM-3 Lyo-DP)

Phase 1

Daiichi Sankyo
Daiichi Sankyo

La Jolla, California, United States and 21 other locations

type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Sunvozertinib

Phase 1, Phase 2

Dizal Pharma

La Jolla, California, United States and 123 other locations

Lung cancer is the leading cause of cancer deaths. Advances in the systemic treatment of non-small cell lung cancer...

Active, not recruiting
Lung Cancer
Drug: Osimertinib
Drug: Abemaciclib

Phase 2

University of California San Diego
University of California San Diego

La Jolla, California, United States of America

This is an international, randomized, open-label, Phase 3 study designed to evaluate whether the potent and selective RET inhibitor, pralsetinib, imp...

Active, not recruiting
Lung Neoplasm
RET-fusion Non Small Cell Lung Cancer
Drug: Cisplatin
Drug: Pembrolizumab

Phase 3

Roche
Roche

San Diego, California, United States and 98 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems